Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 (Anrikefon) for Uremic Pruritus in Hemodialysis Patients
NCT04470154Phase 2Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Aug 2020
- Primary completion
- Oct 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hsk21542 in uremic pruritus, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Aug 2020; status: completed.
02
Drugs
hsk21542
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT04470154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470154.